drugset
drugset / Trial / NCT04224246

Impact of Gamma-OH on Sleep in ICU Patients

NCT04224246 ↗

Phase 2 Completed 20 enrolled Poitiers University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The Main objective of the trial is to assess sleep quality with Gamma-OH® in patients difficult to wean from mechanical ventilation in the ICU.

Timeline

Start
2020-02-27
Primary completion
2023-02-09
Completion
2023-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gamma Hydroxybutyrate Unknown 20 mg/kg Intravenous

Indications

No indication recorded.